PSAT1 Antibody, FITC conjugated
- 
								中文名稱:PSAT1兔多克隆抗體, FITC偶聯(lián)
- 
								貨號(hào):CSB-PA018838LC01HU
- 
								規(guī)格:¥880
- 
								其他:
產(chǎn)品詳情
- 
											產(chǎn)品名稱:Rabbit anti-Homo sapiens (Human) PSAT1 Polyclonal antibody
- 
											Uniprot No.:
- 
											基因名:PSAT1
- 
											別名:EC 2.6.1.52 antibody; Endometrial progesterone induced protein antibody; EPIP antibody; MGC1460 antibody; NLS2 antibody; Phosphohydroxythreonine aminotransferase antibody; phosphoserine aminotransferase 1 antibody; Phosphoserine aminotransferase antibody; PSA antibody; PSAT antibody; Psat1 antibody; PSATD antibody; SERC_HUMAN antibody
- 
											宿主:Rabbit
- 
											反應(yīng)種屬:Human
- 
											免疫原:Recombinant Human Phosphoserine aminotransferase protein (104-206AA)
- 
											免疫原種屬:Homo sapiens (Human)
- 
											標(biāo)記方式:FITC
- 
											克隆類(lèi)型:Polyclonal
- 
											抗體亞型:IgG
- 
											純化方式:>95%, Protein G purified
- 
											濃度:It differs from different batches. Please contact us to confirm it.
- 
											保存緩沖液:Preservative: 0.03% Proclin 300
 Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
- 
											產(chǎn)品提供形式:Liquid
- 
											儲(chǔ)存條件:Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
- 
											貨期:Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
- 
											用途:For Research Use Only. Not for use in diagnostic or therapeutic procedures.
相關(guān)產(chǎn)品
靶點(diǎn)詳情
- 
											功能:Catalyzes the reversible conversion of 3-phosphohydroxypyruvate to phosphoserine and of 3-hydroxy-2-oxo-4-phosphonooxybutanoate to phosphohydroxythreonine.
- 
											基因功能參考文獻(xiàn):- PSAT1 protein and mRNA levels were significantly associated to poor outcome to tamoxifen treatment of breast cancer. PMID: 28522855
- PSAT1, which is overexpressed in ER-negative breast cancers, is activated by ATF4 and promotes cell cycle progression via regulation of the GSK3beta/beta-catenin/cyclin D1 pathway. PMID: 29216929
- Data suggest that phosphoserine aminotransferase 1 (PSAT1) may be a promising anticancer therapeutic target. . PMID: 27372650
- High expression of PSAT is associated with Colon Cancer. PMID: 26439504
- PSAT1 expression positively correlates with the levels of phosphorylated cyclin D1 in non-small cell lung cancer. PMID: 25142862
- phosphoserine aminotransferase deficiency is associated with Neu-Laxova syndrome. PMID: 25152457
- we propose an idea that PSAT1 may be implicated in altered serine metabolism and schizophrenia spectrum conditions. PMID: 20955740
- nucleotide sequence and enzymatic activity of two isoforms generated by alternative splicing; differential expression depending upon tissue specificity and cellular proliferation status PMID: 12633500
- Overexpression of phosphoserine aminotransferase is associated with colorectal cancer development PMID: 18221502
 顯示更多 收起更多 
- 
											相關(guān)疾?。?/div>Phosphoserine aminotransferase deficiency (PSATD); Neu-Laxova syndrome 2 (NLS2)蛋白家族:Class-V pyridoxal-phosphate-dependent aminotransferase family, SerC subfamily組織特異性:Expressed at high levels in the brain, liver, kidney and pancreas, and very weakly expressed in the thymus, prostate, testis and colon.數(shù)據(jù)庫(kù)鏈接:
Most popular with customers
- 
                                            
- 
                                            Phospho-YAP1 (S127) Recombinant Monoclonal Antibody Applications: ELISA, WB, IHC Species Reactivity: Human 
- 
                                            
- 
                                            
- 
                                            
- 
                                            
- 
                                            
- 
                                            
 
 













 
         
           
  
          